Cargando…

Targeted Delivery of Liposomal Temozolomide Enhanced Anti-Glioblastoma Efficacy through Ultrasound-Mediated Blood–Brain Barrier Opening

Glioblastoma (GBM) is the commonest form of primary brain tumor in the central nervous system, with median survival below 15 months and only a 25% two-year survival rate for patients. One of the major clinical challenges in treating GBM is the presence of the blood–brain barrier (BBB), which greatly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Zhuqing, Huang, Xiuxian, Wang, Jieqiong, Cai, Feiyan, Zhao, Ping, Yan, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401148/ https://www.ncbi.nlm.nih.gov/pubmed/34452234 http://dx.doi.org/10.3390/pharmaceutics13081270

Ejemplares similares

Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study
por: Wei, Kuo-Chen, et al.
Publicado: (2013)

Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent
por: Dong, Qian, et al.
Publicado: (2018)

Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue
por: Amarandi, Roxana-Maria, et al.
Publicado: (2022)

Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment
por: Liu, Hao-Li, et al.
Publicado: (2014)

Dovitinib enhances temozolomide efficacy in glioblastoma cells
por: Thanasupawat, Thatchawan, et al.
Publicado: (2017)

Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood–Brain Barrier Opening via Lipid-PLGA Nanobubbles
por: Yan, Yiran, et al.
Publicado: (2021)

Ultrasound-Induced Blood-Brain-Barrier Opening Enhances Anticancer Efficacy in the Treatment of Glioblastoma: Current Status and Future Prospects
por: Deng, Zhiting, et al.
Publicado: (2019)

Low-Level Laser Treatment Induces the Blood-Brain Barrier Opening and the Brain Drainage System Activation: Delivery of Liposomes into Mouse Glioblastoma
por: Semyachkina-Glushkovskaya, Oxana, et al.
Publicado: (2023)

Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting
por: Chu, Liuxiang, et al.
Publicado: (2018)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
por: Wang, Yong, et al.
Publicado: (2019)

Blood-brain barrier opening-based local delivery of 80 nm-sized liposomes in mice using pulsed focused ultrasound
por: Kovacs, Zsofia, et al.
Publicado: (2015)

Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism
por: Zhao, Zhenran, et al.
Publicado: (2023)

Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
por: Wang, Xiang, et al.
Publicado: (2014)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts
por: Shen, Yuanyuan, et al.
Publicado: (2017)

Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
por: Semyachkina-Glushkovskaya, Oxana, et al.
Publicado: (2022)

Transferrin-Conjugated PLGA Nanoparticles for Co-Delivery of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023)

Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
por: Gholamin, Sharareh, et al.
Publicado: (2019)

One-Year Outcome of Multiple Blood–Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma
por: Park, So Hee, et al.
Publicado: (2020)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
por: Wen, Patrick Yung, et al.
Publicado: (2020)

Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment
por: Belhadj, Zakia, et al.
Publicado: (2017)

Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
por: Grafals-Ruiz, Nilmary, et al.
Publicado: (2020)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Pharmacokinetic Analysis of (111)In-Labeled Liposomal Doxorubicin in Murine Glioblastoma after Blood-Brain Barrier Disruption by Focused Ultrasound
por: Yang, Feng-Yi, et al.
Publicado: (2012)

A Disposable Microfluidic Device for Controlled Drug Release from Thermal-Sensitive Liposomes by High Intensity Focused Ultrasound
por: Meng, Long, et al.
Publicado: (2015)

Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma
por: Przystal, Justyna Magdalena, et al.
Publicado: (2019)

Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
por: Drljača, Jovana, et al.
Publicado: (2022)

Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma
por: Li, Yatian, et al.
Publicado: (2023)

RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study
por: Beier, Christoph P, et al.
Publicado: (2009)

Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems †
por: Petrenko, Daria, et al.
Publicado: (2022)

Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound
por: Kim, Yoon-Seok, et al.
Publicado: (2022)

Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin
por: Ye, Xi, et al.
Publicado: (2022)

Polymer–Temozolomide Conjugates as Therapeutics for Treating Glioblastoma
por: Ward, Sarah M., et al.
Publicado: (2018)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Considering the Experimental Use of Temozolomide in Glioblastoma Research
por: Herbener, Verena J., et al.
Publicado: (2020)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4aqji1imjf41r53mep4can1s4l